RCDTF
Price
$65.44
Change
+$9.40 (+16.77%)
Updated
Jun 13 closing price
Capitalization
10.63B
RHHBY
Price
$40.44
Change
-$0.71 (-1.73%)
Updated
Jul 3 closing price
Capitalization
250.69B
17 days until earnings call
Interact to see
Advertisement

RCDTF vs RHHBY

Header iconRCDTF vs RHHBY Comparison
Open Charts RCDTF vs RHHBYBanner chart's image
Recordati Industria Chimica e Farmaceutica S.p.A
Price$65.44
Change+$9.40 (+16.77%)
Volume$300
Capitalization10.63B
Roche Holding
Price$40.44
Change-$0.71 (-1.73%)
Volume$624.51K
Capitalization250.69B
RCDTF vs RHHBY Comparison Chart in %
Loading...
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCDTF vs. RHHBY commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCDTF is a Hold and RHHBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (RCDTF: $65.44 vs. RHHBY: $40.44)
Brand notoriety: RCDTF and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RCDTF: 121% vs. RHHBY: 38%
Market capitalization -- RCDTF: $10.63B vs. RHHBY: $250.69B
RCDTF [@Pharmaceuticals: Major] is valued at $10.63B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCDTF’s FA Score shows that 1 FA rating(s) are green whileRHHBY’s FA Score has 2 green FA rating(s).

  • RCDTF’s FA Score: 1 green, 4 red.
  • RHHBY’s FA Score: 2 green, 3 red.
According to our system of comparison, RCDTF is a better buy in the long-term than RHHBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCDTF’s TA Score shows that 1 TA indicator(s) are bullish while RHHBY’s TA Score has 5 bullish TA indicator(s).

  • RCDTF’s TA Score: 1 bullish, 1 bearish.
  • RHHBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than RCDTF.

Price Growth

RCDTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.05%. For the same industry, the average monthly price growth was +0.58%, and the average quarterly price growth was +9.03%.

Reported Earning Dates

RHHBY is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.05% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($251B) has a higher market cap than RCDTF($10.6B). RCDTF has higher P/E ratio than RHHBY: RCDTF (26.11) vs RHHBY (19.46). RHHBY YTD gains are higher at: 19.796 vs. RCDTF (17.825). RHHBY has higher annual earnings (EBITDA): 19.1B vs. RCDTF (615M). RHHBY has more cash in the bank: 7.51B vs. RCDTF (231M). RCDTF has less debt than RHHBY: RCDTF (1.58B) vs RHHBY (25.4B). RHHBY has higher revenues than RCDTF: RHHBY (60B) vs RCDTF (1.99B).
RCDTFRHHBYRCDTF / RHHBY
Capitalization10.6B251B4%
EBITDA615M19.1B3%
Gain YTD17.82519.79690%
P/E Ratio26.1119.46134%
Revenue1.99B60B3%
Total Cash231M7.51B3%
Total Debt1.58B25.4B6%
FUNDAMENTALS RATINGS
RCDTF vs RHHBY: Fundamental Ratings
RCDTF
RHHBY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
5579
SMR RATING
1..100
4199
PRICE GROWTH RATING
1..100
4350
P/E GROWTH RATING
1..100
5017
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (15) in the null industry is in the same range as RCDTF (26). This means that RHHBY’s stock grew similarly to RCDTF’s over the last 12 months.

RCDTF's Profit vs Risk Rating (55) in the null industry is in the same range as RHHBY (79). This means that RCDTF’s stock grew similarly to RHHBY’s over the last 12 months.

RCDTF's SMR Rating (41) in the null industry is somewhat better than the same rating for RHHBY (99). This means that RCDTF’s stock grew somewhat faster than RHHBY’s over the last 12 months.

RCDTF's Price Growth Rating (43) in the null industry is in the same range as RHHBY (50). This means that RCDTF’s stock grew similarly to RHHBY’s over the last 12 months.

RHHBY's P/E Growth Rating (17) in the null industry is somewhat better than the same rating for RCDTF (50). This means that RHHBY’s stock grew somewhat faster than RCDTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCDTFRHHBY
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
13%
Bearish Trend 5 days ago
43%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
46%
MACD
ODDS (%)
Bearish Trend 5 days ago
14%
Bearish Trend 5 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
18%
Bearish Trend 5 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
18%
Bearish Trend 5 days ago
52%
Advances
ODDS (%)
N/A
Bullish Trend 26 days ago
51%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
46%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
38%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPCPF4.60N/A
N/A
KASIKORNBANK Public Co. Ltd.
LCSHF7.59N/A
N/A
Lancashire Holdings Ltd.
MLLCF4.22N/A
N/A
Molecular Partners AG
MSTH0.04N/A
N/A
Mystic Holdings Inc.
DTRK0.38-0.15
-28.62%
DATATRAK International, Inc.

RCDTF and

Correlation & Price change

A.I.dvisor tells us that RCDTF and RHHBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RCDTF and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCDTF
1D Price
Change %
RCDTF100%
N/A
RHHBF - RCDTF
3%
Poorly correlated
N/A
RHHBY - RCDTF
3%
Poorly correlated
-1.73%
PTKFY - RCDTF
0%
Poorly correlated
N/A
PTKFF - RCDTF
0%
Poorly correlated
N/A
SNPHY - RCDTF
-0%
Poorly correlated
+1.80%
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-1.73%
RHHVF - RHHBY
66%
Loosely correlated
-2.91%
RHHBF - RHHBY
36%
Loosely correlated
N/A
ABBV - RHHBY
21%
Poorly correlated
-0.77%
JNJ - RHHBY
20%
Poorly correlated
+0.29%
CHGCY - RHHBY
20%
Poorly correlated
-0.89%
More